Illumina Investors
Illumina is a prominent venture capital fund based in San Diego, California, established in 1998 The firm specializes in investments within the life sciences sector, focusing on innovative technologies that enhance genomic research and healthcare With a significant investment scale of $96,000,000, Illumina actively supports early-stage companies that are poised to transform the landscape of genomics and personalized medicine The funds strategic approach emphasizes fostering advancements that align with its commitment to improving human health through cutting-edge science and technology
Employee Number:
5001-10000
Investors Number:
19
Funding Status:
IPO
Headquarters:
USA
Last Funding Date:
2023-01-04
Technology:
Neurological Disorders
Estimated Revenue:
$500M to $1B
Founded Date:
1998
Last Funding Type:
Post-IPO Debt
Investor Type:
Venture Capital Funds
Total Funding:
778000000.0
Number Of Exists:
6
Investment Stage:
Early Stage Venture, Late Stage Venture
Industry:
FemTech
Acquisitions Number:
Made Acquisitions